These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 17546667)

  • 1. Mesoporous silicon in drug delivery applications.
    Salonen J; Kaukonen AM; Hirvonen J; Lehto VP
    J Pharm Sci; 2008 Feb; 97(2):632-53. PubMed ID: 17546667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface chemistry of porous silicon and implications for drug encapsulation and delivery applications.
    Jarvis KL; Barnes TJ; Prestidge CA
    Adv Colloid Interface Sci; 2012 Jul; 175():25-38. PubMed ID: 22521238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porous silicon-cell penetrating peptide hybrid nanocarrier for intracellular delivery of oligonucleotides.
    Rytkönen J; Arukuusk P; Xu W; Kurrikoff K; Langel U; Lehto VP; Närvänen A
    Mol Pharm; 2014 Feb; 11(2):382-90. PubMed ID: 24341621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface chemistry and pore size affect carrier properties of mesoporous silicon microparticles.
    Limnell T; Riikonen J; Salonen J; Kaukonen AM; Laitinen L; Hirvonen J; Lehto VP
    Int J Pharm; 2007 Oct; 343(1-2):141-7. PubMed ID: 17600644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Surface Chemistry on the Release of an Antibacterial Drug from Nanostructured Porous Silicon.
    Wang M; Hartman PS; Loni A; Canham LT; Bodiford N; Coffer JL
    Langmuir; 2015 Jun; 31(22):6179-85. PubMed ID: 25970551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in porous silicon technology for drug delivery.
    Barnes TJ; Jarvis KL; Prestidge CA
    Ther Deliv; 2013 Jul; 4(7):811-23. PubMed ID: 23883125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface engineering of porous silicon microparticles for intravitreal sustained delivery of rapamycin.
    Nieto A; Hou H; Moon SW; Sailor MJ; Freeman WR; Cheng L
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):1070-80. PubMed ID: 25613937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional porous silicon for therapeutic drug delivery and imaging.
    Santos HA; Bimbo LM; Lehto VP; Airaksinen AJ; Salonen J; Hirvonen J
    Curr Drug Discov Technol; 2011 Sep; 8(3):228-49. PubMed ID: 21291407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug delivery via porous silicon: a focused patent review.
    Kulyavtsev PA; Spencer RP
    Pharm Pat Anal; 2017 Mar; 6(2):77-85. PubMed ID: 28248125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the physical state of drug molecules in mesoporous silicon with different surface chemistries.
    Riikonen J; Mäkilä E; Salonen J; Lehto VP
    Langmuir; 2009 Jun; 25(11):6137-42. PubMed ID: 19466777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabrication and Characterization of a Porous Silicon Drug Delivery System with an Initiated Chemical Vapor Deposition Temperature-Responsive Coating.
    McInnes SJ; Szili EJ; Al-Bataineh SA; Vasani RB; Xu J; Alf ME; Gleason KK; Short RD; Voelcker NH
    Langmuir; 2016 Jan; 32(1):301-8. PubMed ID: 26654169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of surface chemistry of porous silicon microparticles on glucagon-like peptide-1 (GLP-1) loading, release and biological activity.
    Huotari A; Xu W; Mönkäre J; Kovalainen M; Herzig KH; Lehto VP; Järvinen K
    Int J Pharm; 2013 Sep; 454(1):67-73. PubMed ID: 23834832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of iCVD and porous silicon for the development of a controlled drug delivery system.
    McInnes SJ; Szili EJ; Al-Bataineh SA; Xu J; Alf ME; Gleason KK; Short RD; Voelcker NH
    ACS Appl Mater Interfaces; 2012 Jul; 4(7):3566-74. PubMed ID: 22720638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole.
    Kinnari P; Mäkilä E; Heikkilä T; Salonen J; Hirvonen J; Santos HA
    Int J Pharm; 2011 Jul; 414(1-2):148-56. PubMed ID: 21601623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tunable sustained intravitreal drug delivery system for daunorubicin using oxidized porous silicon.
    Hou H; Nieto A; Ma F; Freeman WR; Sailor MJ; Cheng L
    J Control Release; 2014 Mar; 178():46-54. PubMed ID: 24424270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesoporous silicon: a platform for the delivery of therapeutics.
    Prestidge CA; Barnes TJ; Lau CH; Barnett C; Loni A; Canham L
    Expert Opin Drug Deliv; 2007 Mar; 4(2):101-10. PubMed ID: 17335408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein delivery based on uncoated and chitosan-coated mesoporous silicon microparticles.
    Pastor E; Matveeva E; Valle-Gallego A; Goycoolea FM; Garcia-Fuentes M
    Colloids Surf B Biointerfaces; 2011 Dec; 88(2):601-9. PubMed ID: 21855304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silicon-polymer hybrid materials for drug delivery.
    McInnes SJ; Voelcker NH
    Future Med Chem; 2009 Sep; 1(6):1051-74. PubMed ID: 21425994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanostructured porous silicon-polymer-based hybrids: from biosensing to drug delivery.
    Bonanno LM; Segal E
    Nanomedicine (Lond); 2011 Dec; 6(10):1755-70. PubMed ID: 22122584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of the Pore Texture in Nanoporous Silicon via Chemical Dissolution.
    Secret E; Wu CC; Chaix A; Galarneau A; Gonzalez P; Cot D; Sailor MJ; Jestin J; Zanotti JM; Cunin F; Coasne B
    Langmuir; 2015 Jul; 31(29):8121-8. PubMed ID: 26135844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.